Product Pipeline

ShilpaBio is leveraging its core capabilities in molecular biology, cancer biology and translational sciences to build a pipeline of affordable biologic therapies.

Biosimilars

Our Pipeline Products

Program
Indication
  • Disc.
  • Pre-Clinical
  • Ph1
  • Ph2
  • Ph3
  • La
Etanercept Biosimilar SBDM-01
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis
  • Phase 1
Adalimumab Biosimilar SBDM-02
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease
  • Launch
Aflibercept Biosimilar SBDM-03
Neovascular (Wet) Age-Related Macular Degeneration
Neovascular (Wet) Age-Related Macular Degeneration
  • Phase 3
Abatacept Biosimilar SBDM-04
Adult Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis
Adult Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis
  • Pre-C
SBDM-05
Myocardial Infarction
Myocardial Infarction
  • Dev.
SBDM-06
Anemia associated with Chemotherapy
Anemia associated with Chemotherapy
  • Dev.
SBDM-07
Ovarian hyperstimulation
Ovarian hyperstimulation
  • Dev.
SBDM-08
Colon Cancer, Lung Cancer
Colon Cancer, Lung Cancer
  • Dev.
SBDM-09
Lung cancer, Head & Neck cancer
Lung cancer, Head & Neck cancer
  • Dev.
SBDM-010
Multiple Myeloma
Multiple Myeloma
  • Dev.
SBDM-011
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
  • Dev.